Although the “not-too-distant future” was not defined in the editorial, cancer is still with us, and researchers are still seeking to understand how p53 functions as a tumor suppressor and how best to translate this understanding to benefit cancer patients [2,3]. The gene discussed is TP53; the disease is cancer.